Literature DB >> 18461655

Transcriptional silencing of Dickkopf gene family by CpG island hypermethylation in human gastrointestinal cancer.

Tadateru Maehata1, Hiroaki Taniguchi, Hiroyuki Yamamoto, Katsuhiko Nosho, Yasushi Adachi, Nobuki Miyamoto, Chie Miyamoto, Noriyuki Akutsu, Satoshi Yamaoka, Fumio Itoh.   

Abstract

AIM: To clarify alterations of Dickkopfs (Dkks) and Kremen2 (Krm2) in gastrointestinal cancer.
METHODS: We investigated the expression profiles and epigenetic alterations of Dkks and Krm2 genes in gastrointestinal cancer using RT-PCR, tissue microarray analysis, and methylation specific PCR (MSP). Cancer cells were treated with the demethylating agent and/or histone deacetylase inhibitor. WST-8 assays and in vitro invasion assays after treatment with specific siRNA for those genes were performed.
RESULTS: Dkks and Krm2 expression levels were reduced in a certain subset of the gastrointestinal cancer cell lines and cancer tissues. This was correlated with promoter hypermethylation. There were significant correlations between Dkks over-expression levels and beta-catenin over-expression in colorectal cancer. In colorectal cancers with beta-catenin over-expression, Dkk-1 expression levels were significantly lower in those with lymph node metastases than in those without. Down-regulation of Dkks expression by siRNA resulted in a significant increase in cancer cell growth and invasiveness in vitro.
CONCLUSION: Down-regulation of the Dkks associated to promoter hypermethylation appears to be frequently involved in gastrointestinal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18461655      PMCID: PMC2709050          DOI: 10.3748/wjg.14.2702

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.

Authors:  José Manuel González-Sancho; Oscar Aguilera; José Miguel García; Natalia Pendás-Franco; Cristina Peña; Santiago Cal; Antonio García de Herreros; Félix Bonilla; Alberto Muñoz
Journal:  Oncogene       Date:  2005-02-03       Impact factor: 9.867

2.  Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.

Authors:  Hiroaki Taniguchi; Hiroyuki Yamamoto; Tamaki Hirata; Nobuki Miyamoto; Mariko Oki; Katsuhiko Nosho; Yasushi Adachi; Takao Endo; Kohzoh Imai; Yasuhisa Shinomura
Journal:  Oncogene       Date:  2005-11-24       Impact factor: 9.867

3.  The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF.

Authors:  T Ishitani; J Ninomiya-Tsuji; S Nagai; M Nishita; M Meneghini; N Barker; M Waterman; B Bowerman; H Clevers; H Shibuya; K Matsumoto
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

Review 4.  WNT/PCP signaling pathway and human cancer (review).

Authors:  Masaru Katoh
Journal:  Oncol Rep       Date:  2005-12       Impact factor: 3.906

5.  Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction.

Authors:  A Glinka; W Wu; H Delius; A P Monaghan; C Blumenstock; C Niehrs
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

6.  Dickkopf-3/REIC functions as a suppressor gene of tumor growth.

Authors:  Sen-Yung Hsieh; Pei-Shan Hsieh; Cheng-Tang Chiu; Wai-Ying Chen
Journal:  Oncogene       Date:  2004-12-09       Impact factor: 9.867

7.  Comparative genomics on DKK2 and DKK4 orthologs.

Authors:  Yuriko Katoh; Masaru Katoh
Journal:  Int J Mol Med       Date:  2005-09       Impact factor: 4.101

8.  Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.

Authors:  Hiroyuki Yamamoto; Akravit Vinitketkumnuen; Yasushi Adachi; Hiroaki Taniguchi; Tamaki Hirata; Nobuki Miyamoto; Katsuhiko Nosho; Arisa Imsumran; Masahiro Fujita; Masao Hosokawa; Yuji Hinoda; Kohzoh Imai
Journal:  Carcinogenesis       Date:  2004-08-27       Impact factor: 4.944

9.  Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.

Authors:  O Aguilera; M F Fraga; E Ballestar; M F Paz; M Herranz; J Espada; J M García; A Muñoz; M Esteller; J M González-Sancho
Journal:  Oncogene       Date:  2006-02-20       Impact factor: 9.867

10.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

View more
  35 in total

1.  Dickkopf (Dkk)-3 and β-catenin expressions increased in the transition from normal oral mucosal to oral squamous cell carcinoma.

Authors:  Masae Fujii; Naoki Katase; Mathieu Lefeuvre; Mehmet Gunduz; Rosario Rivera Buery; Ryo Tamamura; Hidetsugu Tsujigiwa; Hitoshi Nagatsuka
Journal:  J Mol Histol       Date:  2011-09-20       Impact factor: 2.611

Review 2.  Dickkopf1: a tumor suppressor or metastasis promoter?

Authors:  Mitchell E Menezes; Daniel J Devine; Lalita A Shevde; Rajeev S Samant
Journal:  Int J Cancer       Date:  2011-11-02       Impact factor: 7.396

3.  Dkk1 and Dkk2 regulate epicardial specification during mouse heart development.

Authors:  Matthew D Phillips; Mahua Mukhopadhyay; Cristina Poscablo; Heiner Westphal
Journal:  Int J Cardiol       Date:  2010-05-02       Impact factor: 4.164

4.  Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro.

Authors:  Yu-Mei Gu; Yi-Hui Ma; Wu-Gan Zhao; Jie Chen
Journal:  World J Gastroenterol       Date:  2011-09-07       Impact factor: 5.742

5.  Polycomb complex PRC1 as gatekeeper of intestinal stem cell identity.

Authors:  Nicolas Léveillé; Louis Vermeulen
Journal:  Stem Cell Investig       Date:  2016-06-15

6.  Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.

Authors:  Naoki Shinno; Hirokazu Kimura; Ryota Sada; Shuji Takiguchi; Masaki Mori; Katsumi Fumoto; Yuichiro Doki; Akira Kikuchi
Journal:  Oncogene       Date:  2018-03-22       Impact factor: 9.867

7.  Dickkopfs and Wnt/β-catenin signalling in liver cancer.

Authors:  Sarwat Fatima; Nikki P Lee; John M Luk
Journal:  World J Clin Oncol       Date:  2011-08-10

8.  Dkk-1 inhibits intestinal epithelial cell migration by attenuating directional polarization of leading edge cells.

Authors:  Stefan Koch; Christopher T Capaldo; Stanislav Samarin; Porfirio Nava; Irmgard Neumaier; Arne Skerra; David B Sacks; Charles A Parkos; Asma Nusrat
Journal:  Mol Biol Cell       Date:  2009-09-23       Impact factor: 4.138

9.  Absence of Dickkopf (Dkk)-3 protein expression is correlated with longer disease-free survival and lower incidence of metastasis in head and neck squamous cell carcinoma.

Authors:  Naoki Katase; Mathieu Lefeuvre; Mehmet Gunduz; Esra Gunduz; Levent Bekir Beder; Reidar Grenman; Masae Fujii; Ryo Tamamura; Hidetsugu Tsujigiwa; Hitoshi Nagatsuka
Journal:  Oncol Lett       Date:  2011-11-08       Impact factor: 2.967

10.  Parathyroid hormone-related protein inhibits DKK1 expression through c-Jun-mediated inhibition of β-catenin activation of the DKK1 promoter in prostate cancer.

Authors:  H Zhang; C Yu; J Dai; J M Keller; A Hua; J L Sottnik; G Shelley; C L Hall; S I Park; Z Yao; J Zhang; L K McCauley; E T Keller
Journal:  Oncogene       Date:  2013-06-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.